Greenville Pharmaceutical research, Inc.

Greenville, South Carolina 29615

0 studies enrolling now · 8 studies all time

What they study most

Asthma, COPD, Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, Chronic Idiopathic Constipation, Chronic Obstructive Pulmonary Disease (COPD), HSIL, Irritable Bowel Syndrome With Constipation, Low Back Pain

Studies at this site

• REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) — Completed
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation — Completed
• A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD — Completed
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed
• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• 12-Week Study in Adult Subjects With Asthma — Completed